🔗 Share this article

Chancellor Rachel Reeves has stated she is planning "specific measures to tackle household expense pressures" in the upcoming financial statement.

Speaking to media outlets, she emphasized that curbing inflation is a joint responsibility of both the government and the Bank of England.

The United Kingdom's inflation rate is forecast to be the most elevated among the G7 industrialized countries this year and the following year.

Possible Energy Cost Measures

Sources suggest the administration could intervene to reduce energy bills, for instance by reducing the present 5% rate of VAT charged on energy.

An additional approach is to cut some of the policy costs currently included in bills.

Budgetary Constraints and Expert Expectations

The government will obtain the latest assessment from the official forecaster, the OBR, on Monday, which will clarify how much scope there is for these actions.

The view from the majority of experts is that Reeves will have to announce tax increases or expenditure reductions in order to adhere to her self-imposed debt limits.

Previously on the same day, analysis suggested there was a £22bn deficit for the chancellor to resolve, which is at the more modest range of forecasts.

"There's a shared job between the Bank of England and the administration to further reduce some of the drivers of price increases," the Chancellor stated to the BBC in the US capital, at the yearly gatherings of the International Monetary Fund and global financial institution.

Tax Pledges and Global Issues

While a great deal of the focus has been on likely tax rises, the Treasury chief said the latest data from the fiscal watchdog had not changed her pledge to manifesto promises not to raise tax levels on income tax, sales tax or National Insurance.

She blamed an "unpredictable global environment" with increasing geopolitical and trade tensions for the fiscal revenue measures, likely to be focused on those "wealthiest."

International Trade Disputes

Referring to concerns about the United Kingdom's economic relations with China she said: "The UK's national security invariably take priority."

Last week's declaration by Chinese authorities to strengthen trade restrictions on critical minerals and other resources that are key for advanced tech manufacturing led US President the US President to suggest an extra 100% import tax on imports from the Asian country, raising the possibility of an full-scale commercial conflict between the two global powers.

The US Treasury Secretary labeled China's move "commercial pressure" and "a international production control attempt."

Questioned on considering the American proposal to join its battle with China, the Chancellor said she was "very concerned" by China's measures and called on the Beijing authorities "to avoid restrictions and restrict access."

She said the move was "damaging for the global economy and creates further headwinds."

"In my view there are areas where we should confront China, but there are also significant prospects to export to China's economy, including banking sector and other areas of the economic system. We've got to get that balance right."

The chancellor also confirmed she was collaborating with international partners "regarding our own critical minerals strategy, so that we are less reliant."

NHS Drug Pricing and Investment

The Chancellor also admitted that the cost the NHS spends on medicines could rise as a result of current talks with the Trump administration and its drugs companies, in exchange for lower tariffs and investment.

A number of the world's largest pharmaceutical manufacturers have said in recent statements that they are either delaying or canceling operations in the United Kingdom, with several attributing the insufficient payments they are obtaining.

Last month, the Science Minister said the price the NHS spends on drugs would must go up to halt businesses and pharmaceutical investment leaving the United Kingdom.

The Chancellor stated to the BBC: "It has been observed due to the pricing regime, that clinical trials, new drugs have not been available in the UK in the manner that they are in other continental states."

"Our aim is to make sure that individuals receiving care from the National Health Service are able to receive the top critical medicines in the world. And so we are looking at all of that, and... seeking to attract additional investment into the UK."